3,4-dihydroxyphenylacetic acid (DOPAC) and the rat mesolimbic dopaminergic pathway: drug effects and evidence for somatodendritic mechanisms

British Journal of Pharmacology
P M Beart, A L Gundlach

Abstract

1 Drug effects on dopamine catabolism of the mesolimbic dopaminergic pathway have been investigated using a sensitive radioenzymatic assay for 3,4-dihydroxyphenylacetic acid (DOPAC). 2 Turnover of DOPAC was less rapid in the ventral tegmentum (containing somata and dendrites) than in the nucleus accumbens (containing nerve terminals): 9 and 115 ng g-1 min-1 for ventral tegmentum and nucleus accumbens respectively. 3 Reserpine (5 mg/kg, 1 h) elevated DOPAC concentration to a greater extent in ventral tegmentum than in nucleus accumbens. 4 Neuroleptic drugs elevated DOPAC levels in ventral tegmentum and nucleus accumbens. Thioridazine, sulpiride and clozapine, thought to act preferentially on the mesolimbic system, caused a similar elevation in both brain regions. 5 gamma-Butyrolactone (750 mg/kg) caused a significant decrease in the DOPAC concentration in ventral tegmentum after 0.5 and 1 h, while DOPAC levels in nucleus accumbens were not significantly altered at these time intervals. 6 Similarities exist between the dopamine catabolism in somatodendritic and nerve terminal regions of mesolimbic dopaminergic neurones in the response to neuroleptic drugs, but differences in catabolism are evident following certain pharmacologica...Continue Reading

References

Jun 13, 1975·Science·L L Iversen
Jan 1, 1976·International Review of Neurobiology·F C ColpaertJ E Leysen
Nov 24, 1977·Experimental Brain Research·C J WilsonE Fifková
Aug 15, 1977·European Journal of Pharmacology·F KaroumR J Wyatt
Jun 1, 1976·European Journal of Pharmacology·B H Westerink, J Korf
Mar 18, 1976·Nature·J KorfB H Westerink
Mar 18, 1976·Nature·L B GeffenL L Iversen
Aug 1, 1973·Archives of General Psychiatry·J R Stevens
Aug 1, 1972·Biochemical Pharmacology·J R Walters, R H Roth

❮ Previous
Next ❯

Citations

Jan 1, 1981·Psychopharmacology·A L Gundlach, P M Beart
Jan 1, 1981·The Journal of Pharmacy and Pharmacology·A L Gundlach, P M Beart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here